Skip to main content

AI Bias Analysis

4 models · Takes ~15 seconds

Science Daily

Ozempic and similar weight-loss drugs linked to 30% lower breast cancer risk

ScienceDaily Composite
ShareXFacebook

A large study found that women taking GLP-1 drugs, the medication class behind Ozempic, Wegovy, Mounjaro, and Zepbound, were about 30% less likely to develop breast cancer. Researchers say the findings are promising but not yet proof, and clinical trials are now being planned to test whether these drugs could help prevent breast cancer.

S

Source

Science Daily

Read full article at Science Daily

Opens original article in a new tab

Advertisement

Related Science Stories

Smart surfaces face zero gravity test in boiling heat experiments
Phys.org

Smart surfaces face zero gravity test in boiling heat experiments

A research team led by Davoud Jafari at the University of Twente, in collaboration with the University of Pisa, has completed a series of parabolic flight experiments to investigate advanced smart surfaces under rapidly changing gravity conditions. Conducted aboard the Air Zero G aircraft operated by Novespace, the campaign integrated additive manufacturing, boiling heat transfer and electric field control into a single experimental platform as part of the #SmartSkin project.

Read more →
Advertisement